BioHarvest Sciences seeks dual listing on Tel Aviv Stock Exchange

Go back to BioHarvest Sciences seeks dual listing on Tel Aviv Stock Exchange

BioHarvest Sciences Registers for Dual Listing on the Tel Aviv Stock Exchange (TASE)

September 3, 2026 7:02 AM EDT

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - September 3, 2026) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0), a leader in Botanical Synthesis technology and sustainable plant-based molecule development today announced its intention to offer its ordinary shares on the Tel Aviv Stock Exchange (TASE) and to become dual-listed for trade on both the Nasdaq and TASE markets. BioHarvest expects its shares to begin trading on the TASE on September 8, 2026.

Dr Zaki Rakib, CEO of BioHarvest Sciences, commented, "BioHarvest is entering an exciting new phase of growth, built on the strength of our... More